Sun Pharma receives amalgamation order from NCLT
Mumbai: Sun Pharmaceutical Industries (Sun Pharma) has received the order passed by National Company Law Tribunal (NCLT) at Ahmedabad bench in the matter of Scheme of Arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments and the company and their respective members and creditors, the company said.
The approval received from the NCLT will be filed in E-Form INC-29 by the company with the registrar of companies, Gujarat and thereafter, the amalgamation shall be effective from the appointed date, April 1, 2017, said the company in a BSE filing on Monday.
Sun Pharma was trading at Rs 468 per share, down by Rs 4.50 or 0.95% as at 0921 hours on Wednesday, on the BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd